Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK1 | Q13464 | 13/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | KDR | P35968 | 1/20 | 0.42 |
| ▸ | RPS6KA5 | O75582 | 1/20 | 0.41 |
| ▸ | CDC7 | O00311 | 1/20 | 0.41 |
| ▸ | CDK2 | P24941 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.40 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19089378 | 0.85 | RPS6KA5 (0.59) | ROCK1MAPTKDRRPS6KA5CDC7 | |
| SCHEMBL5096812 | 0.84 | ROCK1 (0.49) | ROCK1MAPTRPS6KA5CDC7CDK2 | |
| SCHEMBL12018249 | 0.80 | ROCK1 (0.52) | ROCK1 | |
| SCHEMBL144515 | 0.79 | KDR (0.57) | ROCK1KDRCDK2 | |
| SCHEMBL7976140 | 0.79 | MAPK8 (0.61) | ROCK1 | |
| SCHEMBL5096228 | 0.78 | ROCK1 (0.46) | ROCK1MAPTHTR2C | |
| SCHEMBL28337545 | 0.77 | RPS6KA5 (0.53) | ROCK1MAPTRPS6KA5HTR2CGRM1 | |
| SCHEMBL14193374 | 0.76 | MAPK8 (0.62) | — | |
| SCHEMBL19533417 | 0.75 | CDK2 (0.67) | ROCK1MAPTRPS6KA5CDC7CDK2 | |
| SCHEMBL3814633 | 0.74 | MAPK8 (0.71) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1615898-B1 | 2-Aminopyrimidine derivatives and their medical use | NOVARTIS AG (CH) | 2014-10-29 | — | — | EP | disclosed |